PATENT CLAIM ANALYSIS

Application Number: 15749558
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "04400A"]

Abstract:
A method of treating cancer in a subject is disclosed. The method comprises administering to the subject: (i) a therapeutically effective amount of an inhibitory agent that down-regulates an amount of a polypeptide selected from the group consisting of BCL-2, MCL-1 and cyclin D1; and (ii) a therapeutically effective amount of a CXCR4 binding agent that increases the expression of miR-15a and/or 16-1, thereby treating the cancer.

Claim (Index 26):
A method of treating cancer or a neurodegenerative disease in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of gp120 or CXCL12, thereby treating cancer or neurodegenerative disease, with the proviso that the cancer is not prostate cancer.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 88.0
- Lexical Diversity: 1.57143
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15007002', '12978086', '13881695', '14988275', '13806929']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7517320561233017
- 35 USC 102 Novelty (BERT): 0.5156935161134645
- Combined Prediction Score: 0.728128202122318
- Mean Citation Score: 261.351658
- Max Citation Score: 276.67712
- Similarity Product: 169.48292913757325

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test